ES2093838T3 - Inhibidor de fosfolipasa a2. - Google Patents

Inhibidor de fosfolipasa a2.

Info

Publication number
ES2093838T3
ES2093838T3 ES92913882T ES92913882T ES2093838T3 ES 2093838 T3 ES2093838 T3 ES 2093838T3 ES 92913882 T ES92913882 T ES 92913882T ES 92913882 T ES92913882 T ES 92913882T ES 2093838 T3 ES2093838 T3 ES 2093838T3
Authority
ES
Spain
Prior art keywords
represent
phospholipase
independently hydrogen
inhibitor
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92913882T
Other languages
English (en)
Inventor
Mitsuaki Ohtani
Shigeru Matsutani
Tadashi Yoshida
Kazushige Shionogi Seiy Tanaka
Yasuhiko Fujii
Kazuhiro Shirahase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2093838T3 publication Critical patent/ES2093838T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/90—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl and carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

UN NUEVO DERIVADO DE TIELOCINA QUE TIENE UNA ACTIVIDAD INHIBIDORA A LA FOSFOLIPASA A2, REPRESENTADO POR LA FORMULA GENERAL (I), O UNA SAL DEL MISMO, EN DONDE DE R1 A R6 REPRESENTAN CADA UNO, INDEPENDIENTEMENTE, HIDROGENO, ALQUILO INFERIOR, ALCOXI INFERIOR, HIDROXI O HALOGENO; E1 Y E2 REPRESENTAN CADA UNO, INDEPENDIENTEMENTE, HIDROGENO O UN RESIDUO DE ESTER; M Y N REPRESENTAN CADA UNA, INDEPENDIENTEMENTE, UN ENTERO DE 0 A 4; E YQUEDAN REPRESENTADOS POR LAS FORMULAS SIGUIENTES -CH2CH2-, -CH = CH-, (II), (III), (IV), (V), (VI), (VII).
ES92913882T 1991-07-03 1992-06-24 Inhibidor de fosfolipasa a2. Expired - Lifetime ES2093838T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16284791 1991-07-03

Publications (1)

Publication Number Publication Date
ES2093838T3 true ES2093838T3 (es) 1997-01-01

Family

ID=15762376

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92913882T Expired - Lifetime ES2093838T3 (es) 1991-07-03 1992-06-24 Inhibidor de fosfolipasa a2.

Country Status (10)

Country Link
EP (1) EP0547231B1 (es)
JP (1) JP3403404B2 (es)
KR (1) KR100233343B1 (es)
AT (1) ATE141909T1 (es)
CA (1) CA2090434A1 (es)
DE (1) DE69213184T2 (es)
DK (1) DK0547231T3 (es)
ES (1) ES2093838T3 (es)
GR (1) GR3020898T3 (es)
WO (1) WO1993001157A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100640A1 (en) * 1992-07-23 1994-01-24 Shigeru Matsutani Substitute benzoate derivatives
US5534533A (en) * 1993-10-01 1996-07-09 Shionogi & Co., Ltd. Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
KR20200094734A (ko) 2017-09-22 2020-08-07 주빌런트 에피파드 엘엘씨 Pad 억제제로서의 헤테로사이클릭 화합물
DK3697785T3 (da) 2017-10-18 2023-04-03 Jubilant Epipad LLC Imidazo-pyridine forbindelser som pad-inhibitorer
AU2018362046B2 (en) 2017-11-06 2023-04-13 Jubilant Prodel LLC Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
CA3083374A1 (en) 2017-11-24 2019-05-31 Jubilant Episcribe Llc Heterocyclic compounds as prmt5 inhibitors
AU2019234185A1 (en) 2018-03-13 2020-10-01 Jubilant Prodel LLC. Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1271779A (en) * 1971-01-14 1972-04-26 Celanese Corp Purification of aromatic carboxylic acids
DE2205932A1 (de) * 1972-02-09 1973-08-16 Hoechst Ag Verfahren zur herstellung von methylestern mehrkerniger, aromatischer carbonsaeuren
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼａ▲下２▼阻害物質
JPH04117346A (ja) * 1990-09-04 1992-04-17 Shionogi & Co Ltd ホスホリパーゼａ↓２阻害物質
JPH04159251A (ja) * 1990-10-22 1992-06-02 Shionogi & Co Ltd ホスホリパーゼａ↓２阻害物質

Also Published As

Publication number Publication date
DK0547231T3 (da) 1996-09-16
WO1993001157A1 (en) 1993-01-21
EP0547231A4 (en) 1994-06-08
CA2090434A1 (en) 1993-01-04
KR100233343B1 (ko) 1999-12-01
EP0547231A1 (en) 1993-06-23
GR3020898T3 (en) 1996-11-30
KR930702269A (ko) 1993-09-08
DE69213184T2 (de) 1997-01-09
JP3403404B2 (ja) 2003-05-06
DE69213184D1 (en) 1996-10-02
ATE141909T1 (de) 1996-09-15
EP0547231B1 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
DE69929877D1 (de) BENZOCHINONDERIVATE ENTHALTENDE HEMMER VON NF-kB
DK345989A (da) Quinolinderivater
DE69111619T2 (de) 1,4-benzothiazedinderivat.
FI914187A (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
FI904915A0 (fi) Kinolinderivat, deras framstaellning och anvaendning.
ES2093838T3 (es) Inhibidor de fosfolipasa a2.
DE69612611T2 (de) Triazin-derivate
FI914526A (fi) Foerening, dess framstaellning och anvaendning.
DE69023408D1 (de) Glykosidasehemmende Piperidinverbindungen.
DK0479175T3 (da) Pradimicinderivater
DE69303333D1 (de) Substituierte Benzoate-Derivate
DK0455899T3 (da) Prostaglandin I-analog
DE69314929T2 (de) Benzolderivate
ATE309212T1 (de) Optisch aktive 1-phenylpyrrolidonderivate
ES2184311T3 (es) Polioxaalcanocarboxilatos de estaño y composiciones que los contienen.
ITMI912104A1 (it) Poliglucosidi da idrossialchilsorbitolo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 547231

Country of ref document: ES